🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ana De Jesus‐Acosta

Johns Hopkins University

ORCID: 0000-0002-3225-3024

Also affiliated with Sidney Kimmel Comprehensive Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Molecular Determinants of Retinoic Acid Sensitivity in Pancreatic Cancer

(2023)10.1158/1078-0432.c.6520908
Top 100%
0DataRank
Top 100%0 citations

Dipankar Pramanik, Radha Mukherjee, Nathaniel R. Campbell, Sathyanarayanan Elumalai, Roeland F. de Wilde +6 more

Papers

Driven by 10 papers — median percentile 0. Top paper: “A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma”.

A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma

Nature Communications(2023)10.1038/s41467-023-39196-9
N/A
1.4DataRank · unranked
87 citations

Carol Judkins, Keyu Li, Su Jin Lim, Jessica Hoare, Rose Parkinson +24 more

Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal Adenocarcinoma

Cancer Research Communications(2022)10.1158/2767-9764.crc-22-0343
N/A
0.722DataRank · unranked
12 citations

Su Jin Lim, Jennifer N. Durham, Ana De Jesus‐Acosta, Katherine M. Bever, Daniel A. Laheru +6 more

Neoadjuvant and adjuvant antitumor vaccination alone or combination with PD1 blockade and CD137 agonism in patients with resectable pancreatic adenocarcinoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.558
N/A
0.345DataRank · unranked
9 citations

Carol Judkins, Su Jin Lim, Hao Wang, Rose Parkinson, Jessica Gai +15 more

Randomized phase II study of platinum and etoposide (EP) versus temozolomide and capecitabine (CAPTEM) in patients (pts) with advanced G3 non-small cell gastroenteropancreatic neuroendocrine neoplasms (GEPNENs): ECOG-ACRIN EA2142.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4020
N/A
0DataRank · unranked
13 citations

Paul J. Catalano, George A. Fisher, Daniel B. Rubin, Andrei Iagaru, David S. Klimstra +11 more

Data from Molecular Determinants of Retinoic Acid Sensitivity in Pancreatic Cancer

(2023)10.1158/1078-0432.c.6520908
Top 100%
0DataRank
Top 100%0 citations

Dipankar Pramanik, Radha Mukherjee, Nathaniel R. Campbell, Sathyanarayanan Elumalai, Roeland F. de Wilde +6 more

Data from Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal Adenocarcinoma

(2023)10.1158/2767-9764.c.6550898.v1
N/A
0DataRank · unranked
0 citations

Su Jin Lim, Jennifer N. Durham, Ana De Jesus‐Acosta, Katherine M. Bever, Daniel A. Laheru +6 more

Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adjuvant Vaccine in Patients with Resectable Pancreatic Adenocarcinoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2974
N/A
0DataRank · unranked
78 citations

Ding Ding, Barish H. Edil, Carol Judkins, Jennifer N. Durham, Dwayne L. Thomas +32 more

Nivolumab and Relatlimab for the Treatment of Patients with Unresectable or Metastatic Mismatch Repair–Proficient Colorectal Cancer

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-0002
N/A
0DataRank · unranked
11 citations

Won Jin Ho, Daniel Shu, Jennifer N. Durham, Madelena Brancati, Heather Davis Bruning +23 more

Prognostic value of tumor deposits in stage III colon cancer patients, a post-hoc analysis of CALGB/SWOG 80702 phase III study.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.10
N/A
0DataRank · unranked
0 citations

Qian Shi, Jeffrey P. Meyers, Zhaohui Jin, Magali Svrcek, Charles S. Fuchs +14 more

Solid Organ Transplantation Is Associated with an Increased Rate of Mismatch Repair Deficiency and PIK3CA Mutations in Colorectal Cancer

Current Oncology(2022)10.3390/curroncol30010006
N/A
0DataRank · unranked
8 citations

Valerie Lee, Hao Wang, Mark Yarchoan, Ana De Jesus‐Acosta, Nilo Azad +7 more